315 related articles for article (PubMed ID: 25750564)
1. Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital.
Choi HK; Kim YK; Kim HY; Park JE; Uh Y
Korean J Intern Med; 2015 Mar; 30(2):219-25. PubMed ID: 25750564
[TBL] [Abstract][Full Text] [Related]
2. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
Ye Y; Li JB; Ye DQ; Jiang ZJ
Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia.
Lee IK; Liu JW
J Microbiol Immunol Infect; 2006 Aug; 39(4):328-34. PubMed ID: 16926980
[TBL] [Abstract][Full Text] [Related]
4. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint.
Tam VH; Gamez EA; Weston JS; Gerard LN; Larocco MT; Caeiro JP; Gentry LO; Garey KW
Clin Infect Dis; 2008 Mar; 46(6):862-7. PubMed ID: 18279040
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
Chang EP; Chiang DH; Lin ML; Chen TL; Wang FD; Liu CY
J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
[TBL] [Abstract][Full Text] [Related]
7. Bacteremia due to Providencia stuartii: review of 49 episodes.
Woods TD; Watanakunakorn C
South Med J; 1996 Feb; 89(2):221-4. PubMed ID: 8578355
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
[TBL] [Abstract][Full Text] [Related]
9. Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia.
Blot S; Vandewoude K; Hoste E; De Waele J; Kint K; Rosiers F; Vogelaers D; Colardyn F
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):912-5. PubMed ID: 14700406
[TBL] [Abstract][Full Text] [Related]
10. Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia.
Kim BN; Woo JH; Ryu J; Kim YS
Infection; 2003 Aug; 31(4):202-7. PubMed ID: 14562942
[TBL] [Abstract][Full Text] [Related]
11. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
[TBL] [Abstract][Full Text] [Related]
12. Clinical aspects and risk factors of nosocomial Stenotrophomonas maltophilia bacteremia episodes in a Turkish intensive care unit.
Tunger O; Vural S; Cetin CB; Keles G; Borand H; Gazi H
J Chemother; 2007 Dec; 19(6):658-64. PubMed ID: 18230546
[TBL] [Abstract][Full Text] [Related]
13. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000).
Kim BN; Kim NJ; Kim MN; Kim YS; Woo JH; Ryu J
Scand J Infect Dis; 2003; 35(2):98-103. PubMed ID: 12693558
[TBL] [Abstract][Full Text] [Related]
14. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
[TBL] [Abstract][Full Text] [Related]
15. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
[TBL] [Abstract][Full Text] [Related]
16. A review of Providencia bacteremia in a general hospital, with a comment on patterns of antimicrobial sensitivity and use.
Prentice B; Robinson BL
Can Med Assoc J; 1979 Sep; 121(6):745-9. PubMed ID: 519613
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.
Joo EJ; Kang CI; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Lee NY; Song JH
Microb Drug Resist; 2011 Jun; 17(2):305-12. PubMed ID: 21381966
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of Providencia bacteremia or bacteriuria.
Wie SH
Korean J Intern Med; 2015 Mar; 30(2):167-9. PubMed ID: 25750557
[No Abstract] [Full Text] [Related]
19. Clinical significance and outcomes of Clostridium perfringens bacteremia--a 10-year experience at a tertiary care hospital.
Yang CC; Hsu PC; Chang HJ; Cheng CW; Lee MH
Int J Infect Dis; 2013 Nov; 17(11):e955-60. PubMed ID: 23578849
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study.
Blot SI; Vandewoude KH; Colardyn FA
Chest; 2003 Apr; 123(4):1208-13. PubMed ID: 12684313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
